Foundation models for discovering robust biomarkers of neurological disorders from dynamic functional connectivity

arXiv cs.AI / 4/27/2026

💬 OpinionIdeas & Deep AnalysisModels & Research

Key Points

  • The paper introduces RE-CONFIRM, a framework to test whether biomarker candidates derived from brain foundation models using dynamic functional connectivity are truly robust.
  • Experiments across five large fMRI datasets for ASD, ADHD, and Alzheimer’s show that standard predictive performance metrics are insufficient for judging biomarker robustness.
  • The authors find that straightforward fine-tuning of foundation models can fail to capture region “hubs” that are known to be implicated in disorders like ASD and ADHD.
  • To address this, they propose Hub-LoRA (a LoRA-based fine-tuning method) that improves performance while yielding biomarkers that align with neurobiology and are supported by meta-analyses.
  • They report that RE-CONFIRM is broadly applicable to robustness evaluation for deep learning models trained on functional MRI, and they provide code on GitHub.

Abstract

Several brain foundation models (FM) have recently been proposed to predict brain disorders by modelling dynamic functional connectivity (FC). While they demonstrate remarkable model performance and zero- or few-shot generalization, the salient features identified as potential biomarkers are yet to be thoroughly evaluated. We propose RE-CONFIRM, a framework for evaluating the robustness of potential biomarker candidates elucidated by deep learning (DL) models including FMs. From experiments on five large datasets of Autism Spectrum Disorder (ASD), Attention-deficit Hyperactivity Disorder (ADHD), and Alzheimer's Disease (AD), we found that although commonly used performance metrics provide an intuitive assessment of model predictions, they are insufficient for evaluating the robustness of biomarkers identified by these models. RE-CONFIRM metrics revealed that simply finetuning FMs leads to models that fail to capture regional hubs effectively, even in disorders where hubs are known to be implicated, such as ASD and ADHD. In view of this, we propose Hub-LoRA (Low-Rank Adaptation) as a fine-tuning technique that enables FMs to not only outperform customised DL models but also produce neurobiologically faithful biomarkers supported by meta-analyses. RE-CONFIRM is generalizable and can be easily applied to ascertain the robustness of DL models trained on functional MRI datasets. Code is available at: https://github.com/SCSE-Biomedical-Computing-Group/RE-CONFIRM.